In this episode, we explore the growing debate around the role of beta blockers after myocardial infarction, especially for patients who have a preserved or only mildly reduced ejection fraction. Recent studies have challenged the long standing assumption that all post MI patients benefit equally, suggesting that while beta blockers remain essential for those with reduced heart function, their advantage may be far less clear in patients with normal LVEF. We break down the emerging evidence, the nuanced benefits seen in patients with mildly reduced LVEF (40 to 49%), and how clinicians are beginning to shift toward a more individualized, LVEF guided approach to post MI care.